Mimicking the osteosarcoma surfaceome on nanoparticles for targeted gene therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Biology

Background:

• Osteosarcoma presents challenges for targeted therapy due to its aggressive nature.
• Developing drug delivery systems that evade immune surveillance and target cancer cells specifically is crucial.

Purpose of the Study:

• To develop and characterize biomimetic nanoparticles coated with osteosarcoma cell membranes for targeted drug delivery.
• To investigate the mechanism of nanoparticle internalization and cytosolic delivery.
• To evaluate the therapeutic efficacy of survivin siRNA-loaded nanoparticles in osteosarcoma.

Main Methods:

• Fabrication of poly(lactic-co-glycolic acid) nanoparticles coated with osteosarcoma cell membranes (CMCNPs).
• In vitro assessment of homotypic targeting, immune evasion (macrophage interaction), and stealth properties (protein adsorption, liver retention).
• Proteomic analysis and inhibitor studies to elucidate the role of Disabled Homolog-2 (Dab2) in nanoparticle internalization.
• In vivo evaluation of tumor penetration, regression, and off-target effects after siRNA delivery.

Main Results:

• CMCNPs exhibited specific binding to osteosarcoma cells and evaded macrophage uptake.
• Reduced protein adsorption and minimal liver retention confirmed the stealth properties of CMCNPs.
• Dab2 was identified as a key mediator for enhanced cytosolic delivery of nanoparticles.
• siRNA-loaded CMCNPs demonstrated significant tumor penetration, regression, and precise survivin gene targeting without off-target effects.

Conclusions:

• Cell membrane-coated nanoparticles offer a promising platform for targeted osteosarcoma therapy.
• The study elucidates the mechanism of Dab2-mediated cytosolic delivery, enhancing therapeutic potential.
• CMCNPs loaded with survivin siRNA show high specificity and efficacy for osteosarcoma management.